Morgan Stanley’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$82K Buy
5,210
+1,990
+62% +$32.8K ﹤0.01% 6334
2026
Q1
$55K Sell
3,220
-2,142
-40% -$37.9K ﹤0.01% 6389
2025
Q4
$91.4K Sell
5,362
-3,687
-41% -$70.5K ﹤0.01% 6241
2025
Q3
$189K Buy
9,049
+3,751
+71% +$73.8K ﹤0.01% 5919
2025
Q2
$89.6K Buy
5,298
+1,699
+47% +$27K ﹤0.01% 6175
2025
Q1
$56.1K Sell
3,599
-4,591
-56% -$67.2K ﹤0.01% 6231
2024
Q4
$116K Sell
8,190
-2,017
-20% -$31.4K ﹤0.01% 5998
2024
Q3
$171K Buy
10,207
+8,228
+416% +$112K ﹤0.01% 5810
2024
Q2
$26.2K Sell
1,979
-486
-20% -$7K ﹤0.01% 6372
2024
Q1
$35.8K Sell
2,465
-10,956
-82% -$169K ﹤0.01% 6331
2023
Q4
$235K Sell
13,421
-111,177
-89% -$1.99M ﹤0.01% 5640
2023
Q3
$2.21M Sell
124,598
-2,892
-2% -$51.5K ﹤0.01% 4327
2023
Q2
$2.3M Buy
127,490
+19,914
+19% +$397K ﹤0.01% 4332
2023
Q1
$2.21M Sell
107,576
-55,474
-34% -$1.24M ﹤0.01% 4400
2022
Q4
$3.49M Buy
163,050
+67,453
+71% +$1.32M ﹤0.01% 4050
2022
Q3
$1.69M Buy
95,597
+934
+1% +$19.5K ﹤0.01% 4546
2022
Q2
$2.21M Sell
94,663
-318
-0.3% -$6.69K ﹤0.01% 4452
2022
Q1
$2.21M Sell
94,981
-23,197
-20% -$570K ﹤0.01% 4445
2021
Q4
$3.39M Sell
118,178
-138,809
-54% -$4.77M ﹤0.01% 4130
2021
Q3
$9.61M Buy
256,987
+21,097
+9% +$822K ﹤0.01% 2935
2021
Q2
$10.7M Buy
235,890
+78,455
+50% +$3.34M ﹤0.01% 2893
2021
Q1
$6.13M Buy
157,435
+32,413
+26% +$1.33M ﹤0.01% 3200
2020
Q4
$4.88M Buy
125,022
+9,121
+8% +$323K ﹤0.01% 3281
2020
Q3
$3.89M Buy
115,901
+113,101
+4,039% +$3.87M ﹤0.01% 2962
2020
Q2
$89K Buy
+2,800
New +$76.8K ﹤0.01% 5461

Other funds holding KURE

Morgan Stanley's KURE Position: Q2 2026 in Review

Morgan Stanley increased its KraneShares MSCI All China Health Care Index ETF (KURE) stake by 62% in Q2 2026, buying an estimated $32.8K and bringing the position to 5,210 shares worth $82K. The position accounts for ﹤0.01% of the portfolio, ranked #6334.

Morgan Stanley first reported a position in KURE in Q2 2020 and has held it in 25 quarters since. The position peaked at $10.7M in Q2 2021. 13 funds tracked by Wall St. Rank hold KURE as of Q2 2026.

  • Morgan Stanley held 5,210 shares of KraneShares MSCI All China Health Care Index ETF worth $82K as of Q2 2026.
  • Morgan Stanley bought 1,990 KraneShares MSCI All China Health Care Index ETF shares in Q2 2026, an estimated $32.8K.
  • KraneShares MSCI All China Health Care Index ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6334 holding.
  • Morgan Stanley first reported a position in KraneShares MSCI All China Health Care Index ETF in Q2 2020 and has held it in 25 quarters since.
  • Morgan Stanley's KraneShares MSCI All China Health Care Index ETF position peaked at $10.7M in Q2 2021.
  • 13 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.